HEADER 08-MAY-06 2GXC TITLE MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO TITLE 2 2,4-BIS{[4-(N-CYCLOPENTYLDIAMINOMETHYL)PHENYL]}FURAN. COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- COMPND 3 3'; COMPND 4 CHAIN: A, B; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: MODEL BUILT KEYWDS MODEL BUILT, MINOR GROOVE BINDING, FURAN DERIVATIVE EXPDTA THEORETICAL MODEL AUTHOR SAHER A.SHAIKH REVDAT 1 17-OCT-06 2GXC 0 JRNL AUTH SAHER A.SHAIKH,B JAYARAM JRNL TITL A SWIFT ALL-ATOM ENERGY BASED COMPUTATIONAL JRNL TITL 2 PROTOCOL TO PREDICT DNA-DRUG BINDING AFFINITY AND JRNL TITL 3 DELTATM JRNL REF TO BE PUBLISHED 2006 JRNL REFN REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMBER 8 REMARK 3 AUTHORS : D.A. CASE, T.A. DARDEN, T.E. CHEATHAM, III, REMARK 3 C.L. SIMMERLING, J. WANG, R.E. DUKE, R. LUO, REMARK 3 K.M. MERZ, B. WANG, D.A. PEARLMAN, M. CROWLEY, REMARK 3 S. BROZELL, V. TSUI, H. GOHLKE, J. MONGAN, V. REMARK 3 HORNAK, G. CUI, P. BEROZA, C. SCHAFMEISTER, J.W. REMARK 3 CALDWELL, W.S. ROSS, AND P.A. KOLLMAN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GXC COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 08-MAY-2006. REMARK 100 THE RCSB ID CODE IS RCSB037663. REMARK 103 REMARK 103 THERE ARE NON-WATSON-CRICK HYDROGEN BONDS BETWEEN THE REMARK 103 FOLLOWING ATOMS: REMARK 103 O2 C A 1 AND N1 G B 24 REMARK 103 N1 A A 6 AND N3 T B 19 REMARK 105 REMARK 105 THE PROTEIN DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS REMARK 105 NOMENCLATURE FOR ATOMS OF THE DEOXYRIBOSE/RIBOSE MOIETY REMARK 105 RATHER THAN THAT OF THE NUCLEOSIDE CHEMISTS. THE RING REMARK 105 OXYGEN ATOM IS LABELLED O4* INSTEAD OF O1*. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: MODEL BUILDING FOLLOWED BY OPTIMIZATION BY ENERGY REMARK 220 MINIMIZATION AND MOLECULAR DYNAMICS SIMULATIONS WITH REMARK 220 EXPLICIT SOLVENT AND COUNTERIONS. THIS THEORETICAL MODEL REMARK 220 ENTRY WAS NOT ANNOTATED AND NOT VALIDATED BY THE WWPDB REMARK 220 STAFF AND THEREFORE MAY NOT CONFORM TO THE PDB FORMAT. REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. SEQRES 1 A 12 C G C G A A T T C G C G SEQRES 1 B 12 C G C G A A T T C G C G HET 1AF 25 67 HETNAM 1AF 2,4-BIS{[4-(N-CYCLOPENTYLDIAMINOMETHYL)PHENYL]}FURAN FORMUL 3 1AF C28 H36 N4 O CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 43 0 1 0 0 0 0 6 0 0 0 2 END